Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 27;25(2):266-271.
doi: 10.5935/1518-0557.20200094.

High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment

Tie-Cheng Sun  1 , Shan-Jie Zhou  1 , Ling-Li Song  1 , Jian-Hua Li  2 , Xi Chen  3 , Li Tian  1   3
Affiliations

High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment

Tie-Cheng Sun et al. JBRA Assist Reprod. .

Abstract

Objective: To investigate if high anti-Müllerian hormone (AMH) concentration is a useful tool to predict the outcome of assisted reproductive treatment.

Methods: Retrospective cohort study involving 520 patients who underwent IVF/ICSI procedures in a university hospital. We measured the serum AMH level on day 3 of the menstrual cycle. Based on AMH levels, we divided the patients into three groups as follows: low (<25th percentile) AMH group, average (25th to 75th percentile) AMH group and high (>75th percentile) AMH group. We recorded the fertilization rate (FR), the number of oocytes retrieved, the number of good quality embryos (GQEs) and the clinical pregnancy rate (CPR).

Results: There was no difference between the three AMH groups in terms of maternal age, body mass index (BMI), follicle-stimulating hormone (FSH), estradiol (E2), luteinizing hormone (LH) and testosterone (T) in the IVF/ICSI cycles. The women in the high serum AMH group had a higher number of retrieved oocytes than those in the low or average AMH groups (p < 0.01) in the IVF/ICSI cycles. Compared with the low or average AMH groups, the women with high AMH levels had a higher number of good quality embryos (GQEs) in the IVF/ICSI cycles (p < 0.01). However, high AMH women had no significantly higher clinical pregnancy rate (CPR) compared to the women in the low or average AMH groups. In addition, for the prediction of CPR, the AMH levels alone were not an independent predictor of CPR for IVF and ICSI cycles in the ROC curve analysis.

Conclusions: High anti-Müllerian hormone levels are an independent predictor of the number of retrieved oocytes and good quality embryos (GQEs), but might not reflect the likelihood of higher clinical pregnancy rates (CPR) in IVF/ICSI treatment.

Keywords: IVF/ICSI; anti-Müllerian hormone (AMH); clinical pregnancy rate (CPR); good quality embryos (GQEs); number of retrieved oocytes.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

All authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
The correlation between NOC, GQEs and AMH levels
Figure 2
Figure 2
ROC curve analysis of AMH and CPR in IVF/ICSI cycles
See this image and copyright information in PMC

References

    1. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26:1270–1283. doi: 10.1093/humrep/der037. - DOI - PubMed
    1. Bhide P, Escriba M, Srikantharajah A, Joshi H, Gudi A, Shah A, Acharya G, Homburg R. Anti-Mullerian hormone (AMH) and embryo quality assessed by time-lapse imaging (TLI): a cross-sectional observational study. Arch Gynecol Obstet. 2017;296:583–587. doi: 10.1007/s00404-017-4453-2. - DOI - PubMed
    1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718. doi: 10.1093/humupd/dml034. - DOI - PubMed
    1. Broer SL, Dólleman M, Van Disseldorp J, Broeze KA, Opmeer BC, Bossuyt PM, Eijkemans MJ, Mol BW, Broekmans FJ, IPD-EXPORT Study Group Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertil Steril. 2013;100:420–9.e7. doi: 10.1016/j.fertnstert.2013.04.024. - DOI - PubMed
    1. Bukman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update. 2001;7:581–590. doi: 10.1093/humupd/7.6.581. - DOI - PubMed

Publication types

Substances